<p>Aveanna Healthcare（纳斯达克代码：AVAH - 获取免费报告）于周四公布了其财报。公司报告本季度每股收益为 0.18 美元，超出分析师一致预期的 0.13 美元，超出幅度为 0.05 美元，FiscalAI 报道。该公司本季度的收入为 6.4792 亿美元，而分析师预期为 6.1322 亿美元。Aveanna Healthcare 的股本回报率为 481.69%，净利润率为 9.25%。该公司的季度收入同比增长 15.9%。</p>
<p>获取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
<p>以下是 Aveanna Healthcare 电话会议的关键要点：</p>
<ul>
<li><strong>Aveanna 发布了强劲的第一季度业绩</strong>，收入约为 6.48 亿美元，同比增长 15.9%，调整后的息税折旧摊销前利润（EBITDA）为 8440 万美元，同比增长 25.2%，得益于更好的费率、更高的交易量和运营效率。</li>
<li><strong>公司提高了 2026 财年的指引</strong>，预计收入为 25.6 亿至 25.8 亿美元，调整后的 EBITDA 为 3.28 亿至 3.32 亿美元，不包括待完成的 Family First 收购。</li>
<li><strong>优先支付者战略在所有业务中持续获得 traction</strong>，第一季度新增 4 个 PDS 优先支付者协议、4 个家庭健康协议和 2 个医疗解决方案协议。</li>
<li><strong>管理层表示新的 CMS 家庭健康暂停不会影响 Aveanna</strong> 或其 Family First 收购，并且不会改变公司的 2026 年或 2027 年的商业计划。</li>
<li><strong>资产负债表和现金生成保持稳健</strong>，流动性约为 5.25 亿美元，净杠杆率为 3.8 倍，管理层重申了进一步去杠杆化的路径，并计划进行小规模收购。</li>
</ul>
<h2>Aveanna Healthcare 股价上涨 9.9%</h2>
<p>周四，AVAH 股票上涨 0.67 美元，达到 7.44 美元。该公司交易了 4,276,480 股股票，而其平均交易量为 1,274,675 股。Aveanna Healthcare 的 52 周低点为 3.73 美元，52 周高点为 10.32 美元。公司的流动比率为 1.32，速动比率为 1.32，债务与股本比率为 6.62。该公司的市值为 16.2 亿美元，市盈率为 7.29，贝塔值为 1.93。公司的 50 日简单移动平均线为 6.70 美元，200 日简单移动平均线为 7.94 美元。</p>
<h2>内部交易活动</h2>
<p>在相关消息中，首席财务官 Matthew Buckhalter 于 2 月 19 日（星期四）出售了 13,512 股公司的股票，交易价格为每股 7.21 美元，总交易额为 97,421.52 美元。出售完成后，首席财务官直接持有公司股票 529,243 股，价值约为 3,815,842.03 美元。此次交易代表其持股减少了 2.49%。该交易已在与证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。此外，内部人士 Patrick A. Cunningham 于 2 月 19 日（星期四）出售了 18,436 股公司的股票，交易价格为每股 7.21 美元，总价值为 132,923.56 美元。出售后，该内部人士直接持有公司股票 337,755 股，价值为 2,435,213.55 美元。这代表其持股减少了 5.18%。该交易的披露信息可在 SEC 文件中找到。内部人士在过去三个月内出售了价值 5,458,175 美元的 738,957 股公司股票。公司内部人士持有公司股票的 5.30%。</p>
<h2>机构投资者对 Aveanna Healthcare 的看法</h2>
<p>机构投资者和对冲基金最近买卖了该公司的股票。Quantbot Technologies LP 在第二季度购买了 Aveanna Healthcare 的新股份，价值 43,000 美元。Oxford Asset Management LLP 在第二季度购买了 Aveanna Healthcare 的新股份，价值 64,000 美元。Bayesian Capital Management LP 在第二季度购买了 Aveanna Healthcare 的新股份，价值 85,000 美元。Jain Global LLC 在第四季度购买了 Aveanna Healthcare 的新股份，价值 102,000 美元。最后，Invesco Ltd.在第二季度将其在 Aveanna Healthcare 的持股增加了 31.1%。Invesco Ltd.现在拥有 20,006 股公司股票，价值 105,000 美元，此前在上个季度又购买了 4,742 股。87.96% 的股票由机构投资者持有。</p>
<h2>分析师设定新的目标价</h2>
<p>AVAH 最近成为多份研究报告的主题。Raymond James Financial 将 Aveanna Healthcare 的评级从 “跑赢大盘” 上调至 “强力买入”，并在 3 月 20 日的报告中设定了 13.00 美元的目标价。Truist Financial 将 Aveanna Healthcare 的目标价从 9.00 美元下调至 8.00 美元，并在 4 月 13 日的报告中为该公司设定了 “持有” 评级。Zacks Research 在 2 月 3 日的报告中将 Aveanna Healthcare 的评级从 “强力买入” 下调至 “持有”。BMO Capital Markets 在 3 月 20 日的报告中将 Aveanna Healthcare 的目标价从 11.00 美元下调至 10.00 美元，并为该公司设定了 “跑赢大盘” 评级。最后，Barclays 在 3 月 25 日的报告中将 Aveanna Healthcare 的目标价从 11.00 美元下调至 9.50 美元，并为该公司设定了 “增持” 评级。一位投资分析师对该股票给予了强力买入评级，四位给予了买入评级，六位给予了持有评级。根据 MarketBeat，该股票目前的共识评级为 “适度买入”，共识目标价为 10.25 美元。</p>
<p><strong>查看我们关于 AVAH 的最新报告</strong></p>
<h2>关于 Aveanna Healthcare</h2>
<p>（获取免费报告）</p>
<p>Aveanna Healthcare, Inc NASDAQ: AVAH 是一家全国性的居家医疗服务提供商，专注于为医学复杂和慢性病儿童提供儿科专业护理、治疗及相关支持。该公司提供一系列临床和治疗解决方案，旨在使患者能够在自己舒适的家中接受护理，从而减少住院和长期机构护理的需求。Aveanna 的服务包括注册护士、物理治疗、职业治疗、语言治疗、行为健康咨询以及耐用医疗设备协调。</p>
<p>除了儿科居家健康服务外，Aveanna 还运营成人居家健康和个人护理支持项目，帮助老年人和残疾成年人进行日常生活活动、药物管理和康复治疗。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 Aveanna Healthcare 更好的股票</li>
<li>YETI 在财报超预期和上调前景后反弹</li>
<li>三家领先量子公司的 Q1 财报对比</li>
<li>思科的垂直反弹可能仍处于早期阶段</li>
<li>亚马逊与阿里巴巴：现在显然更具价值的选择</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Aveanna Healthcare 吗？</h2>
<p>在考虑 Aveanna Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Aveanna Healthcare 并不在名单上。</p>
<p>尽管 Aveanna Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AVAH

<p>Aveanna Healthcare（纳斯达克代码：AVAH）报告了第一季度每股收益为 0.18 美元，超出预期 0.05 美元。收入达到 6.4792 亿美元，同比增长 15.9%，超过预期的 6.1322 亿美元。该公司将 2026 年的收入指引上调至 25.6 亿至 25.8 亿美元。公告发布后，股价上涨 9.9%，至 7.44 美元。首席财务官和另一位内部人士出售了股份，而机构持股比例为 87.96%。分析师设定了新的目标价为 13.00 美元，反映出对公司业绩和前景的积极情绪</p>

<p>Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) announced its earnings results on Thursday. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.13 by $0.05, FiscalAI reports. The firm had revenue of $647.92 million during the quarter, compared to analysts' expectations of $613.22 million. Aveanna Healthcare had a return on equity of 481.69% and a net margin of 9.25%.The business's revenue for the quarter was up 15.9% on a year-over-year basis.</p>
<div class="lb-trans"><p>Aveanna Healthcare（纳斯达克代码：AVAH - 获取免费报告）于周四公布了其财报。公司报告本季度每股收益为 0.18 美元，超出分析师一致预期的 0.13 美元，超出幅度为 0.05 美元，FiscalAI 报道。该公司本季度的收入为 6.4792 亿美元，而分析师预期为 6.1322 亿美元。Aveanna Healthcare 的股本回报率为 481.69%，净利润率为 9.25%。该公司的季度收入同比增长 15.9%。</p>
</div><p>Get <strong>Aveanna Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
</div><p>Here are the key takeaways from Aveanna Healthcare's conference call:</p>
<div class="lb-trans"><p>以下是 Aveanna Healthcare 电话会议的关键要点：</p>
</div><ul>
<li><strong>Aveanna posted strong Q1 results</strong> with revenue of about $648 million, up 15.9% year over year, and adjusted EBITDA of $84.4 million, up 25.2%, driven by better rates, higher volumes, and operational efficiencies.</li>
<li><strong>The company raised full-year 2026 guidance</strong> to revenue of $2.56 billion-$2.58 billion and adjusted EBITDA of $328 million-$332 million, excluding the pending Family First acquisition.</li>
<li><strong>Preferred payer strategy continues to gain traction</strong> across all businesses, with 4 new PDS preferred payer agreements, 4 new Home Health agreements, and 2 new Medical Solutions agreements in Q1.</li>
<li><strong>Management said the new CMS Home Health moratorium should not affect Aveanna</strong> or its Family First acquisition, and it does not change the company’s 2026 or 2027 business plans.</li>
<li><strong>Balance sheet and cash generation remain solid</strong>, with liquidity of about $525 million and net leverage at 3.8x, while management reiterated a path toward further deleveraging alongside tuck-in acquisitions.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Aveanna 发布了强劲的第一季度业绩</strong>，收入约为 6.48 亿美元，同比增长 15.9%，调整后的息税折旧摊销前利润（EBITDA）为 8440 万美元，同比增长 25.2%，得益于更好的费率、更高的交易量和运营效率。</li>
<li><strong>公司提高了 2026 财年的指引</strong>，预计收入为 25.6 亿至 25.8 亿美元，调整后的 EBITDA 为 3.28 亿至 3.32 亿美元，不包括待完成的 Family First 收购。</li>
<li><strong>优先支付者战略在所有业务中持续获得 traction</strong>，第一季度新增 4 个 PDS 优先支付者协议、4 个家庭健康协议和 2 个医疗解决方案协议。</li>
<li><strong>管理层表示新的 CMS 家庭健康暂停不会影响 Aveanna</strong> 或其 Family First 收购，并且不会改变公司的 2026 年或 2027 年的商业计划。</li>
<li><strong>资产负债表和现金生成保持稳健</strong>，流动性约为 5.25 亿美元，净杠杆率为 3.8 倍，管理层重申了进一步去杠杆化的路径，并计划进行小规模收购。</li>
</ul>
</div><h2>Aveanna Healthcare Trading Up 9.9%</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 股价上涨 9.9%</h2>
</div><p>Shares of AVAH stock traded up $0.67 on Thursday, reaching $7.44. 4,276,480 shares of the company's stock were exchanged, compared to its average volume of 1,274,675. Aveanna Healthcare has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 6.62. The stock has a market capitalization of $1.62 billion, a PE ratio of 7.29 and a beta of 1.93. The company's fifty day simple moving average is $6.70 and its 200 day simple moving average is $7.94.</p>
<div class="lb-trans"><p>周四，AVAH 股票上涨 0.67 美元，达到 7.44 美元。该公司交易了 4,276,480 股股票，而其平均交易量为 1,274,675 股。Aveanna Healthcare 的 52 周低点为 3.73 美元，52 周高点为 10.32 美元。公司的流动比率为 1.32，速动比率为 1.32，债务与股本比率为 6.62。该公司的市值为 16.2 亿美元，市盈率为 7.29，贝塔值为 1.93。公司的 50 日简单移动平均线为 6.70 美元，200 日简单移动平均线为 7.94 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In related news, CFO Matthew Buckhalter sold 13,512 shares of the firm's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $97,421.52. Following the completion of the sale, the chief financial officer directly owned 529,243 shares of the company's stock, valued at approximately $3,815,842.03. This trade represents a 2.49% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Also, insider Patrick A. Cunningham sold 18,436 shares of the firm's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $132,923.56. Following the sale, the insider directly owned 337,755 shares of the company's stock, valued at $2,435,213.55. This represents a 5.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 738,957 shares of company stock worth $5,458,175 in the last three months. Corporate insiders own 5.30% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席财务官 Matthew Buckhalter 于 2 月 19 日（星期四）出售了 13,512 股公司的股票，交易价格为每股 7.21 美元，总交易额为 97,421.52 美元。出售完成后，首席财务官直接持有公司股票 529,243 股，价值约为 3,815,842.03 美元。此次交易代表其持股减少了 2.49%。该交易已在与证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。此外，内部人士 Patrick A. Cunningham 于 2 月 19 日（星期四）出售了 18,436 股公司的股票，交易价格为每股 7.21 美元，总价值为 132,923.56 美元。出售后，该内部人士直接持有公司股票 337,755 股，价值为 2,435,213.55 美元。这代表其持股减少了 5.18%。该交易的披露信息可在 SEC 文件中找到。内部人士在过去三个月内出售了价值 5,458,175 美元的 738,957 股公司股票。公司内部人士持有公司股票的 5.30%。</p>
</div><h2>Institutional Investors Weigh In On Aveanna Healthcare</h2>
<div class="lb-trans"><h2>机构投资者对 Aveanna Healthcare 的看法</h2>
</div><p>Institutional investors and hedge funds have recently bought and sold shares of the company. Quantbot Technologies LP bought a new stake in Aveanna Healthcare during the 2nd quarter valued at $43,000. Oxford Asset Management LLP bought a new stake in Aveanna Healthcare during the 2nd quarter valued at $64,000. Bayesian Capital Management LP bought a new stake in Aveanna Healthcare during the 2nd quarter valued at $85,000. Jain Global LLC bought a new stake in Aveanna Healthcare during the 4th quarter valued at $102,000. Finally, Invesco Ltd. raised its position in Aveanna Healthcare by 31.1% during the 2nd quarter. Invesco Ltd. now owns 20,006 shares of the company's stock valued at $105,000 after purchasing an additional 4,742 shares in the last quarter. 87.96% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近买卖了该公司的股票。Quantbot Technologies LP 在第二季度购买了 Aveanna Healthcare 的新股份，价值 43,000 美元。Oxford Asset Management LLP 在第二季度购买了 Aveanna Healthcare 的新股份，价值 64,000 美元。Bayesian Capital Management LP 在第二季度购买了 Aveanna Healthcare 的新股份，价值 85,000 美元。Jain Global LLC 在第四季度购买了 Aveanna Healthcare 的新股份，价值 102,000 美元。最后，Invesco Ltd.在第二季度将其在 Aveanna Healthcare 的持股增加了 31.1%。Invesco Ltd.现在拥有 20,006 股公司股票，价值 105,000 美元，此前在上个季度又购买了 4,742 股。87.96% 的股票由机构投资者持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的目标价</h2>
</div><p>AVAH has been the subject of a number of recent research reports. Raymond James Financial upgraded Aveanna Healthcare from an &#34;outperform&#34; rating to a &#34;strong-buy&#34; rating and set a $13.00 target price for the company in a report on Friday, March 20th. Truist Financial dropped their target price on Aveanna Healthcare from $9.00 to $8.00 and set a &#34;hold&#34; rating for the company in a report on Monday, April 13th. Zacks Research cut Aveanna Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Tuesday, February 3rd. BMO Capital Markets dropped their target price on Aveanna Healthcare from $11.00 to $10.00 and set an &#34;outperform&#34; rating for the company in a report on Friday, March 20th. Finally, Barclays dropped their target price on Aveanna Healthcare from $11.00 to $9.50 and set an &#34;overweight&#34; rating for the company in a report on Wednesday, March 25th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $10.25.</p>
<div class="lb-trans"><p>AVAH 最近成为多份研究报告的主题。Raymond James Financial 将 Aveanna Healthcare 的评级从 “跑赢大盘” 上调至 “强力买入”，并在 3 月 20 日的报告中设定了 13.00 美元的目标价。Truist Financial 将 Aveanna Healthcare 的目标价从 9.00 美元下调至 8.00 美元，并在 4 月 13 日的报告中为该公司设定了 “持有” 评级。Zacks Research 在 2 月 3 日的报告中将 Aveanna Healthcare 的评级从 “强力买入” 下调至 “持有”。BMO Capital Markets 在 3 月 20 日的报告中将 Aveanna Healthcare 的目标价从 11.00 美元下调至 10.00 美元，并为该公司设定了 “跑赢大盘” 评级。最后，Barclays 在 3 月 25 日的报告中将 Aveanna Healthcare 的目标价从 11.00 美元下调至 9.50 美元，并为该公司设定了 “增持” 评级。一位投资分析师对该股票给予了强力买入评级，四位给予了买入评级，六位给予了持有评级。根据 MarketBeat，该股票目前的共识评级为 “适度买入”，共识目标价为 10.25 美元。</p>
</div><p><strong>View Our Latest Report on AVAH</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 AVAH 的最新报告</strong></p>
</div><h2>About Aveanna Healthcare</h2>
<div class="lb-trans"><h2>关于 Aveanna Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.</p>
<div class="lb-trans"><p>Aveanna Healthcare, Inc NASDAQ: AVAH 是一家全国性的居家医疗服务提供商，专注于为医学复杂和慢性病儿童提供儿科专业护理、治疗及相关支持。该公司提供一系列临床和治疗解决方案，旨在使患者能够在自己舒适的家中接受护理，从而减少住院和长期机构护理的需求。Aveanna 的服务包括注册护士、物理治疗、职业治疗、语言治疗、行为健康咨询以及耐用医疗设备协调。</p>
</div><p>In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.</p>
<div class="lb-trans"><p>除了儿科居家健康服务外，Aveanna 还运营成人居家健康和个人护理支持项目，帮助老年人和残疾成年人进行日常生活活动、药物管理和康复治疗。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Aveanna Healthcare</li>
<li>YETI Rallies After Earnings Beat and Raised Outlook</li>
<li>How the 3 Leading Quantum Firms Stack Up After Q1 Earnings</li>
<li>Cisco’s Vertical Rally May Still Be in the Early Innings</li>
<li>Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Aveanna Healthcare 更好的股票</li>
<li>YETI 在财报超预期和上调前景后反弹</li>
<li>三家领先量子公司的 Q1 财报对比</li>
<li>思科的垂直反弹可能仍处于早期阶段</li>
<li>亚马逊与阿里巴巴：现在显然更具价值的选择</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=AVAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Aveanna Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Aveanna Healthcare 吗？</h2>
</div><p>Before you consider Aveanna Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Aveanna Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Aveanna Healthcare 并不在名单上。</p>
</div><p>While Aveanna Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Aveanna Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Aveanna Healthcare (NASDAQ:AVAH) Releases Earnings Results, Beats Estimates By $0.05 EPS

Market Beat

Aveanna Healthcare

Aveanna Healthcare (NASDAQ:AVAH) 公布了财报，每股收益超出预期 0.05 美元